- Resource Center
- Information center
A business plan for revolutionary biosensor technology co-developed by Fujitsu Laboratories Ltd. and Technische Universitaet Muenchen, ("TUM", Walter Schottky Institute) won second place in the Full Business Plan category of the Munich Business Plan Competition 2010, of 253 teams entered overall. In record time and with high accuracy, the biosensors recognize proteins that are characteristic of specific diseases, and also show if such proteins are changed through the influence of disease or drugs. With support from Fujitsu Laboratories, a start-up team at TUM will be commercializing the biosensors through the EXIST research transfer program run by the German Federal Ministry of Economics and Technology. The award underscores the high level of anticipation for this completely novel protein measuring technology, and its commercial potential in the fields of medical diagnosis, drug development, and proteomics research.
"Dynamic biosensors" runner-up winners of Full Business Plan category, from TUM (Walter Schottky Institute) at awards ceremony of the Munich Business Plan Competition 2010: (foreground, left to right) Dr. Jens Niemax, Dr. Ulrich Rant, Dr. Kenji Arinaga (formerly of Fujitsu Laboratories), Ralf Strasser.
Related press release:
Fujitsu and Technische Universität München Develop
World's First DNA-based Revolutionary Biosensor Technology
- Accurately detects proteins 100 times faster than in the past; dramatically improves disease diagnosis -
Share this page